Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

NCT02271711 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Childhood Medulloblastoma
Recurrent Ependymoma
Recurrent Medulloblastoma

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Natural Killer Cell Therapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]